IL25 and neoplasm: However, IL-17E, likely released by epithelial tuft cells in the presence of intestinal dysbiosis, can promote the progression of hepatocellular carcinoma by favoring alternative activation of macrophages and their CXCL10 secretion in the tumor microenvironment (33).